Article
Heterologous expression of the atypical tetracycline chelocardin reveals the full set of genes required for its biosynthesis
1 Dec 2020
Abstract excerpt
BACKGROUND: Chelocardin (CHD) exhibits a broad-spectrum antibiotic activity and showed promising results in a small phase II clinical study conducted on patients with urinary tract infections. Importantly, CHD was shown to be active also against tetracycline-resistant Gram-negative pathogens, which is gaining even more importance in today's antibiotic crisis. We have demonstrated that modifications of CHD through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
